Learn more

HEALTHBANKS BIOTECH CO LTD

Overview
  • Total Patents
    60
  • GoodIP Patent Rank
    150,710
  • Filing trend
    ⇩ 75.0%
About

HEALTHBANKS BIOTECH CO LTD has a total of 60 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2004. It filed its patents most often in Taiwan, United States and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and basic materials chemistry are PAUL EHRLICH INST BUNDESAMT FU, STICHTING INST DIERHOUDERIJ and CRUCELL HOLLAND BV.

Patent filings per year

Chart showing HEALTHBANKS BIOTECH CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chang Hsiu-Kang 21
#2 Liao Chao-Wei 14
#3 Lo Wei-Yu 11
#4 Liao Chao-We 10
#5 Lin Shang-Chih 9
#6 Tseng Pei-Chi 9
#7 Cheng Wen-Fang 9
#8 Xu Xiang-Rui 7
#9 Chang Hsiu Kang 7
#10 Hwang Kinkai 7

Latest patents

Publication Filing date Title
CN110564685A Serum-free medium and method for expanding hematopoietic stem cells
US2018163177A1 Serum-free culture medium and method for expanding hematopoietic stem cells
TW201731479A Storage equipment and cover device
CN105766890A Method for low temperature preservation of umbilical cord tissue and obtaining of derived stem cells thereof
TWI586804B Cryopreservation of umbilical cord tissue strips for cord tissue-derived stem cells
US2016066566A1 Cryopreservation of umbilical cord tissue strips for cord tissue-derived stem cells
US2015012025A1 Automatic handle assembly for scissors-shearing
TW201311145A Storage, cultivation and application of umbilical cord tissue and derived cell thereof
TW201036889A Storage apparatus for storing products
US2009203884A1 Chimeric hiv fusion proteins as vaccines
TW200951217A Method for promoting differentiation of stem cell into insulin producing cell
US2008206271A1 Fusion antigen used as vaccine
TW200922543A Storage-access apparatus for storing products and storage system thereof
CA2584894A1 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
CN101284130A Method for using a reverse genetic engineering platform to produce protein vaccinces and protein vaccine of avian influenza virus
US2007243587A1 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
EP1882478A1 Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine
US2008008722A1 Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine
TW200724155A Fusion proteins for inhibiting or preventing hpv i
EP1757615A1 Fusion protein for inhibiting cervical cancer